<DOC>
	<DOCNO>NCT00015886</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness combination chemotherapy treat woman breast cancer metastatic treat surgery .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Women With Breast Cancer That Metastatic Can Treated With Surgery</brief_title>
	<detailed_description>OBJECTIVES : - Determine response rate woman locally unresectable metastatic breast cancer treat docetaxel , leucovorin calcium , fluorouracil second third-line chemotherapy . - Evaluate toxic effect regimen patient . - Determine time progression patient treat regimen . OUTLINE : This multicenter study . Patients receive docetaxel IV 1 hour day 1 leucovorin calcium IV 1 hour follow fluorouracil IV 5 minute day 1-3 . Treatment repeat every 4 week 2-8 course absence disease progression unacceptable toxicity . Patients follow every 3 month . PROJECTED ACCRUAL : A total 21-45 patient accrue study within 44 month .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm breast cancer Metastatic unresectable local disease Measurable evaluable disease No ascites pleural effusion metastatic site No brain leptomeningeal metastases Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : 18 Sex : Female Menopausal status : Not specify Performance status : 02 Life expectancy : At least 3 month Hematopoietic : Granulocyte count great 1,500/mm3 Platelet count great 100,000/mm3 Hepatic : Bilirubin normal SGOT/SGPT le 1.5 time upper limit normal ( ULN ) Alkaline phosphatase less 2.5 time ULN Renal : Creatinine great 2 time ULN Cardiovascular : Adequate cardiac function No history significant atherosclerotic coronary disease ( e.g. , uncontrolled angina ) No history significant cardiac arrhythmia Other : No serious medical psychiatric illness would preclude study No active uncontrolled bacterial , viral , fungal infection Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : No prior highdose chemotherapy autologous transplantation Chemotherapy : At least 3 week since prior chemotherapy recover No 2 prior chemotherapy regimens metastatic breast cancer ( addition adjuvant therapy ) No prior docetaxel No prior highdose chemotherapy autologous transplantation Prior paclitaxel allow Endocrine therapy : No concurrent hormonal therapy , except contraception Radiotherapy : At least 3 week since prior radiotherapy recover Concurrent radiotherapy relief localize pain obstruction allow Surgery : At least 2 week since prior major surgery recover Other : No concurrent cytotoxic agent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>stage IV breast cancer</keyword>
	<keyword>recurrent breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
</DOC>